Skip to content
Bomb Report – Lifestyle
Author:
Business Wire
Merck Presents One-Year Results from the Pivotal Phase 2b/3 BRUNELLO Study Evaluating Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, in Adults with Diabetic Macular Edema at AAO 2026
October 10, 2026
Genentech Presents New Phase III One-Year Data for Vamikibart in Uveitic Macular Edema (UME), a Serious Cause of Vision Loss
October 10, 2026
ENSG Investors Have Opportunity to Lead The Ensign Group, Inc. Securities Fraud Lawsuit with SBS Law
October 10, 2026
T-Mobile Crews and Teams Restore Connectivity as Gulf Coast Communities Recover from Hurricane Isaias
October 10, 2026
AXP Investors with $100,000 in Losses Have Opportunity to Join American Express Company Fraud Investigation with SBS Law
October 10, 2026
CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit with SBS Law
October 10, 2026
NCPL Investors Have Opportunity to Lead Netcapital Inc. Securities Fraud Lawsuit with SBS Law
October 10, 2026
Verda Healthcare, Inc. and AstranaCare Partners Form a Multi-State Partnership
October 10, 2026
Investor Alert: Robbins LLP Informs Investors of the Millrose Properties, Inc. Class Action Lawsuit
October 10, 2026
Investor Alert: Robbins LLP Informs Investors of the Compass, Inc. Class Action Lawsuit
October 10, 2026
1
2
3
…
4,862
Next Page
→